aryl-amido-aryl compounds (CoCo)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namearyl-amido-aryl compounds (CoCo)
Drug Alias Nameretinoic acid receptor-alpha agonists (CoCo Therapeutics)retinoic acid receptor-alpha agonists (King's College London)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptor alpha agonists
TargetsRetinoic acid receptor alpha
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKing'S College London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCoCo Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A